Data readouts planned for CLN-978 across all three autoimmune indications in 2026, including single dose and repeat dosing dataCompany to ...

As we reflect on 2025, it is clear that the Troilus Team achieved major technical, regulatory, organizational, and financing milestones required to advance the Project into its next phase of ...